Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice GuidelineDawn L. Hershman, Charles L. Loprinzi|Journal of Clinical Oncology|2014Cited by 1.2k
Colorectal Cancer Surveillance: 2005 Update of an American Society of Clinical Oncology Practice GuidelineChristopher E. Desch, Nicholas J. Petrelli, Al B. Benson et al.|Journal of Clinical Oncology|2005Cited by 565
Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone MetastasesAndrew L. Himelstein, Charles L. Shapiro, Douglas Weckstein et al.|JAMA|2017Cited by 357
Efficacy of gabapentin in the management of chemotherapy‐induced peripheral neuropathyRavi D. Rao, John C. Michalak, Jeff A. Sloan et al.|Cancer|2007Cited by 355
Chemotherapy-Induced Peripheral Neuropathy: Prevention and TreatmentDeirdre R. Pachman, Charles L. Loprinzi, Debra L. Barton et al.|Clinical Pharmacology & Therapeutics|2011Cited by 263